130 related articles for article (PubMed ID: 9659069)
1. Thromboembolic complications and pharmacological prophylaxis in orthopaedic surgery.
Montebugnoli M; Bugamelli S; Bonfatti M; Facchini F; Pignotti E; Cenacchi A
Anaesthesia; 1998 May; 53 Suppl 2():55-6. PubMed ID: 9659069
[TBL] [Abstract][Full Text] [Related]
2. [Assessment of complications of major orthopedic surgery: comparison of indobufen, calcium heparin, and low molecular heparin].
Borghi B; Bassi A; Grazia M; Feoli MA; Pignotti E
Minerva Anestesiol; 1996 Mar; 62(3):93-100. PubMed ID: 8767154
[TBL] [Abstract][Full Text] [Related]
3. [Indobufen and calcium heparin for the prevention of thromboembolism in hip prosthesis surgery in patients who have undergone hemodilution].
Borghi B; Bugamelli S; deSimone N; Montebugnoli M; Ferrari S
Minerva Anestesiol; 1990 Oct; 56(10):1117-20. PubMed ID: 2290518
[No Abstract] [Full Text] [Related]
4. Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Dorr LD; Gendelman V; Maheshwari AV; Boutary M; Wan Z; Long WT
J Bone Joint Surg Am; 2007 Dec; 89(12):2648-57. PubMed ID: 18056497
[TBL] [Abstract][Full Text] [Related]
5. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
6. Anaesthesia and autologous transfusion.
Borghi B; Bassi A; Grazia M; Gargioni G; Pignotti E
Int J Artif Organs; 1995 Mar; 18(3):159-66. PubMed ID: 7499019
[TBL] [Abstract][Full Text] [Related]
7. [Standards and perspectives for thromboembolism prophylaxis].
Rader CP
Orthopade; 2007 Jun; 36(6):560, 562-6. PubMed ID: 17546440
[TBL] [Abstract][Full Text] [Related]
8. Thromboembolic disease in hip replacement surgery.
Salvati E; Gonzales Della Valle A; Zoppi A; Pavone V
Chir Organi Mov; 2005; 90(3):209-28. PubMed ID: 16681100
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.
Freedman KB; Brookenthal KR; Fitzgerald RH; Williams S; Lonner JH
J Bone Joint Surg Am; 2000 Jul; 82-A(7):929-38. PubMed ID: 10901307
[TBL] [Abstract][Full Text] [Related]
10. Cardiology patient pages. Treatment of blood clots.
Goldhaber SZ; Grasso-Correnti N
Circulation; 2002 Nov; 106(20):e138-40. PubMed ID: 12427663
[No Abstract] [Full Text] [Related]
11. [Indications and clinical application of thrombosis prophylaxis. I].
Mittelkötter U; Reith HB; Thiede A
Zentralbl Chir; 2000; 125(7):W49-52. PubMed ID: 10960979
[No Abstract] [Full Text] [Related]
12. Dabigatran: new drug. Continue to use heparin, a better-known option.
Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
[TBL] [Abstract][Full Text] [Related]
13. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
[TBL] [Abstract][Full Text] [Related]
15. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
16. [Preventing venous thromboembolism].
Encke A; Haas S
Chirurg; 2007 Feb; 78(2):110, 112-8. PubMed ID: 17265054
[TBL] [Abstract][Full Text] [Related]
17. Indobufen in the prevention of thromboembolic complications in patients with heart disease. A randomized, placebo-controlled, double-blind study.
Fornaro G; Rossi P; Mantica PG; Caccia ME; Aralda D; Lavezzari M; Pamparana F; Milanesi G
Circulation; 1993 Jan; 87(1):162-4. PubMed ID: 8419003
[TBL] [Abstract][Full Text] [Related]
18. [Low-molecular-weight heparin. Prophylaxis and treatment of thromboembolisms in surgery and obstetrics].
Nikolov A; Kovachev I; Petkov Iu; Dimitrov A
Akush Ginekol (Sofiia); 2000; 39(3):35-40. PubMed ID: 11187995
[No Abstract] [Full Text] [Related]
19. Early antithrombotic prophylaxis with low molecular weight heparin in neurosurgery.
Kleindienst A; Harvey HB; Mater E; Bronst J; Flack J; Herenz K; Haupt WF; Schön R
Acta Neurochir (Wien); 2003 Dec; 145(12):1085-90; discussion 1090-1. PubMed ID: 14663565
[TBL] [Abstract][Full Text] [Related]
20. Pharmacoeconomic analysis of bemiparin and enoxaparin as prophylaxis for venous thromboembolism in total knee replacement surgery.
Honorato J; Gómez-Outes A; Navarro-Quilis A; Martínez-González J; Rocha E; Planès A
Pharmacoeconomics; 2004; 22(13):885-94. PubMed ID: 15329033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]